Theriva (TOVX) market analysis | analyst expectations and growth opportunities remain in focus. Theriva Biologics Inc. (TOVX) closed at $0.30, down 5.73% from the prior session. The stock is approaching a key support level near $0.28, while resistance stands at $0.32. The decline reflects ongoing selling pressure in the micro-cap biotech space amid low trading volumes.
Theriva Biologics (TOVX) Slides 5.73% as Price Nears Critical Support at $0.28 - {个股副标题}
TOVX - Stock Analysis
3974 Comments
1232 Likes
1
{用户名称}
{用户等级}
2 hours ago
{协议答案}
👍 30
Reply
2
{用户名称}
{用户等级}
5 hours ago
{协议答案}
👍 198
Reply
3
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 99
Reply
4
{用户名称}
{用户等级}
1 day ago
{协议答案}
👍 229
Reply
5
{用户名称}
{用户等级}
2 days ago
{协议答案}
👍 76
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.